JP2022525476A5 - - Google Patents
Info
- Publication number
- JP2022525476A5 JP2022525476A5 JP2021556462A JP2021556462A JP2022525476A5 JP 2022525476 A5 JP2022525476 A5 JP 2022525476A5 JP 2021556462 A JP2021556462 A JP 2021556462A JP 2021556462 A JP2021556462 A JP 2021556462A JP 2022525476 A5 JP2022525476 A5 JP 2022525476A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819870P | 2019-03-18 | 2019-03-18 | |
| US62/819,870 | 2019-03-18 | ||
| PCT/US2020/023250 WO2020190990A1 (en) | 2019-03-18 | 2020-03-18 | Tumor-selective combination therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525476A JP2022525476A (ja) | 2022-05-16 |
| JPWO2020190990A5 JPWO2020190990A5 (https=) | 2023-03-23 |
| JP2022525476A5 true JP2022525476A5 (https=) | 2023-03-23 |
Family
ID=72519160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556462A Pending JP2022525476A (ja) | 2019-03-18 | 2020-03-18 | 腫瘍選択的併用療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220160703A1 (https=) |
| EP (1) | EP3942061A4 (https=) |
| JP (1) | JP2022525476A (https=) |
| KR (1) | KR20220004025A (https=) |
| CN (1) | CN113905763A (https=) |
| AU (1) | AU2020240035A1 (https=) |
| BR (1) | BR112021018545A2 (https=) |
| CA (1) | CA3130513A1 (https=) |
| MX (1) | MX2021011301A (https=) |
| WO (1) | WO2020190990A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230128175A (ko) * | 2022-02-25 | 2023-09-04 | 주식회사 온코크로스 | 루복시스타우린을 포함하는 항암용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2619331T (pt) * | 2010-09-22 | 2018-06-01 | Univ Texas | Métodos de tratamento de cancro incluindo rastreio de nqo1 |
| CA2909091C (en) * | 2013-04-09 | 2021-11-02 | The Board Of Trustees Of The University Of Illinois | Tumor-selective combination therapy |
| WO2017025496A1 (en) * | 2015-08-12 | 2017-02-16 | Bayer Pharma Aktiengesellschaft | Pharmaceutical combination for the treatment of cancer |
| SG11201808306PA (en) * | 2016-03-24 | 2018-10-30 | Tragara Pharmaceuticals Inc | Treatment of cancer with tg02 |
| KR102922386B1 (ko) * | 2017-07-21 | 2026-02-04 | 제넨테크, 인크. | 암에 대한 치료 및 진단 방법 |
-
2020
- 2020-03-18 KR KR1020217033464A patent/KR20220004025A/ko not_active Ceased
- 2020-03-18 BR BR112021018545A patent/BR112021018545A2/pt unknown
- 2020-03-18 MX MX2021011301A patent/MX2021011301A/es unknown
- 2020-03-18 US US17/440,787 patent/US20220160703A1/en not_active Abandoned
- 2020-03-18 JP JP2021556462A patent/JP2022525476A/ja active Pending
- 2020-03-18 CN CN202080037114.7A patent/CN113905763A/zh active Pending
- 2020-03-18 WO PCT/US2020/023250 patent/WO2020190990A1/en not_active Ceased
- 2020-03-18 EP EP20773832.9A patent/EP3942061A4/en not_active Withdrawn
- 2020-03-18 CA CA3130513A patent/CA3130513A1/en active Pending
- 2020-03-18 AU AU2020240035A patent/AU2020240035A1/en not_active Abandoned